---
schema_version: "secwatch.filing_event.v1"
accession: "0001156039-26-000063"
form_type: "8-K"
ticker: "ELV"
cik: "0001156039"
company_name: "Elevance Health, Inc."
filed_at: "2026-09-10T10:00:47+00:00"
generated_at: "2026-09-10T10:05:22.479678+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Elevance reaffirms FY2026 EPS guidance: at least $20.10 GAAP, $27.00 adjusted

## Summary
- Reaffirms FY2026 shareholders' EPS guidance of at least $20.10, including ~$6.90 net unfavorable items.
- Excluding items, adjusted shareholders' EPS guidance at least $27.00 per diluted share.
- Reaffirms FY2026 benefit expense ratio guidance of 90.2% ± 50 basis points.
- Guidance reaffirmed during investor meetings over the next several weeks.

## SEC filing metadata
- accession: 0001156039-26-000063
- form_type: 8-K
- ticker: ELV
- cik: 0001156039
- company_name: Elevance Health, Inc.
- filed_at: 2026-09-10T10:00:47+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1156039/000115603926000063/0001156039-26-000063-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1156039/000115603926000063/elv-20260910.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001156039-26-000063
- JSON: https://secwatch.observer/filing/0001156039-26-000063.json
- Plain text: https://secwatch.observer/filing/0001156039-26-000063.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.